PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma

被引:156
|
作者
Atsaves, V. [1 ]
Tsesmetzis, N. [1 ]
Chioureas, D. [1 ]
Kis, L. [1 ,2 ]
Leventaki, V. [3 ]
Drakos, E. [4 ]
Panaretakis, T. [1 ]
Grander, D. [1 ]
Medeiros, L. J. [5 ]
Young, K. H. [5 ]
Rassidakis, G. Z. [1 ,2 ,5 ]
机构
[1] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden
[3] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] Univ Crete, Med Sch, Dept Pathol, Iraklion, Crete, Greece
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
KINASE; SURVIVAL; HODGKIN;
D O I
10.1038/leu.2017.103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1633 / 1637
页数:6
相关论文
共 50 条
  • [41] NPM-ALK Upregulates Jab1/Csn5 through STAT3 Activation in Anaplastic Large Cell Lymphoma: A Novel Function of NPM-ALK That Contributes to PD1/PD-L1 Immune Checkpoint Regulation
    Drakos, Elias
    Stathopoulou, Konstantina
    Li, Lingxiao
    Bilbao, Daniel
    Leventaki, Vasiliki
    Da Silva, Pedro Farrajota Neves
    Atsaves, Vasileios
    Osterborg, Anders
    Medeiros, L. Jeffrey
    Vega, Francisco
    Schatz, Jonathan H.
    Claret, Francois
    Rassidakis, George Z.
    BLOOD, 2019, 134
  • [42] RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma
    Ahmed, Nada
    Ketterling, Rhett P.
    Nowakowski, Grzegorz S.
    Dasari, Surendra
    Feldman, Andrew L.
    HISTOPATHOLOGY, 2022, 81 (02) : 275 - 278
  • [43] In-Vivo Activation Of STAT3 In Angioimmunoblastic T Cell Lymphoma, PTCL Not Otherwise Specified, and ALK Negative Anaplastic Large Cell Lymphoma: Implications For Therapy
    Gupta, Mamta
    Maurer, Matthew J.
    Stenson, Mary
    Wellik, Linda E.
    Han, Jing Jing
    Feldman, Andrew L.
    Habermann, Thomas M.
    Witzig, Thomas E.
    BLOOD, 2013, 122 (21)
  • [44] PD-L1 Is Regulated By Interferon Gamma and Interleukin 6 through STAT1 and STAT3 Signaling in Cutaneous T-Cell Lymphoma
    Kil, Sung Hee
    Estephan, Renee
    Sanchez, James
    Zain, Jasmine M.
    Kadin, Marshall E.
    Young, James W.
    Rosen, Steven T.
    Querfeld, Christiane
    BLOOD, 2017, 130
  • [45] ALK-1-negative anaplastic large-cell lymphoma presenting as a dura-based mass in an infant
    Ahuja, Nishtha
    Sharma, Rahul
    Gupta, Kirti
    Tiewsoh, Karalanglin
    Salunke, Pravin
    Gendle, Chandrashekhar
    Jain, Richa
    Trehan, Amita
    CLINICAL NEUROPATHOLOGY, 2021, 40 (06) : 347 - 353
  • [46] The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma
    Huang, Po-Shuan
    Chung, I-Hsiao
    Lin, Yang-Hsiang
    Lin, Tzu-Kang
    Chen, Wei-Jan
    Lin, Kwang-Huei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [47] A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening
    Zhang, Jing-Ping
    Song, Zhihui
    Wang, Hong-Bo
    Lang, Lang
    Yang, Yuan-Zhong
    Xiao, Wenming
    Webster, Daniel E.
    Wei, Wei
    Barta, Stefan K.
    Kadin, Marshall E.
    Staudt, Louis M.
    Nakagawa, Masao
    Yang, Yibin
    BLOOD, 2019, 134 (02) : 171 - 185
  • [48] Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
    Han, Yajun
    Amin, Hesham A.
    Franko, Bevin
    Frantz, Christine
    Shi, Xinzhe
    Lai, Raymond
    BLOOD, 2006, 108 (08) : 2796 - 2803
  • [49] Refractory Case of ALK-Negative Anaplastic Large-Cell Lymphoma with PAX-5 Expression and T-Cell Receptor-gamma Gene Rearrangement
    Kawakami, Keiki
    Yazaki, Akira
    Ito, Ryugo
    Tono, Yasutaka
    Murata, Tetsuya
    Baba, Yohichiro
    Uchiyama, Tomoko
    Imai, Hiroshi
    Nakamura, Shigeo
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (03) : 251 - 254
  • [50] STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
    Wu, Chengsheng
    Molavi, Ommoleila
    Zhang, Haifeng
    Gupta, Nidhi
    Alshareef, Abdulraheem
    Bone, Kathleen M.
    Gopal, Keshav
    Wu, Fang
    Lewis, Jamie T.
    Douglas, Donna N.
    Kneteman, Norman M.
    Lai, Raymond
    BLOOD, 2015, 126 (03) : 336 - 345